A growing evidence base shows that chronic obstructive pulmonary disease (COPD) is affected by climate and environmental exposures, not only through extreme temperature exposure and air pollution but ...
High temperatures indoors can contribute to respiratory morbidity among chronic obstructive pulmonary disease patients, according to a study in ATS Journals. Researchers examined 69 patients COPD for ...
Pegtarazimod holds promise for effectively treating acute exacerbations of COPD, a major unmet need in COPD treatment.
Health-related quality of life (HRQOL) did not differ significantly between younger and older patients with chronic obstructive pulmonary disease (COPD) suffering from chronic hypercapnic respiratory ...
Adults with vs. without COPD lost more years of life, and the number of lost years from COPD was similar across never, ...
Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...
Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that causes inflammation and lung damage. Lifestyle changes such as an anti-inflammatory diet and supplements can help manage ...
“Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data from more recent years are ...
People living with chronic obstructive pulmonary disease (COPD) typically rely on maintenance inhalers to manage their daily symptoms. They may also take rescue inhalers for sudden breathing ...
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results